Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,551 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.24
-4.72%
2.42
Revenue and Profits:
Net Sales:
349 Million
(Quarterly Results - Mar 2026)
Net Profit:
16 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.64%
0%
1.64%
6 Months
-7.46%
0%
-7.46%
1 Year
0.81%
0%
0.81%
2 Years
-27.47%
0%
-27.47%
3 Years
-35.13%
0%
-35.13%
4 Years
-23.32%
0%
-23.32%
5 Years
-2.84%
0%
-2.84%
Zhuhai Rundu Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.18%
EBIT Growth (5y)
-181.25%
EBIT to Interest (avg)
34.30
Debt to EBITDA (avg)
1.60
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.70
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.84%
ROE (avg)
8.76%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.42
EV to EBIT
-60.13
EV to EBITDA
42.54
EV to Capital Employed
2.14
EV to Sales
2.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.56%
ROE (Latest)
-4.72%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
348.70
292.00
19.42%
Operating Profit (PBDIT) excl Other Income
16.10
33.10
-51.36%
Interest
3.00
3.20
-6.25%
Exceptional Items
-0.00
-0.00
Consolidate Net Profit
15.60
-8.80
277.27%
Operating Profit Margin (Excl OI)
46.20%
-16.30%
6.25%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 19.42% vs -13.17% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 277.27% vs 52.43% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,167.20
1,179.40
-1.03%
Operating Profit (PBDIT) excl Other Income
107.70
181.80
-40.76%
Interest
15.50
17.40
-10.92%
Exceptional Items
-16.60
0.00
Consolidate Net Profit
-63.50
39.90
-259.15%
Operating Profit Margin (Excl OI)
-36.00%
33.20%
-6.92%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.03% vs -7.60% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -259.15% vs -40.36% in Dec 2024
About Zhuhai Rundu Pharmaceutical Co., Ltd. 
Zhuhai Rundu Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






